SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adorbs Inc. – IPO: ‘S-1’ on 1/19/18 – ‘EX-5.1’

On:  Friday, 1/19/18, at 4:57pm ET   ·   Accession #:  1615774-18-439   ·   File #:  333-222631

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 2/20/18   ·   Latest:  ‘S-1’ on 8/7/23   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/19/18  Adorbs Inc.                       S-1                    6:1.0M                                   S2 Filings LLC/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML    290K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML      5K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     69K 
 4: EX-5.1      Opinion re: Legality                                HTML     11K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     11K 
 6: EX-99.1     Miscellaneous Exhibit                               HTML     23K 


EX-5.1   —   Opinion re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 5.1

 

January __, 2017

 

Adorbs Inc. 

243 E. Beech Street

Long Beach, NY 11561

 

Re:   Registration Statement on Form S-1 

 

Ladies and Gentlemen:

 

I am counsel for Adorbs Inc., a Nevada corporation (the “Company”), in connection with the proposed public offering by the Company under the Securities Act of 1933, as amended, of up to 20,000,000 shares of its common stock, $0.001 par value per share (“Common Stock”) through a Registration Statement on Form S-1 (the “Registration Statement”) as to which this opinion is a part, to be filed with the Securities and Exchange Commission.

 

In connection with rendering my opinion as set forth below, I have reviewed and examined originals or copies identified to my satisfaction of the following:

 

(1)Articles of Incorporation, of the Company as filed with the Secretary of State of Nevada;

 

(2)By-laws of the Company;

 

(3)Corporate minutes containing the written resolutions of the Board of Directors of the Company;

 

(4)The Registration Statement and the prospectus contained within the Registration Statement; and

 

(5)The other exhibits of the Registration Statement.

 

I have examined such other documents and records, instruments and certificates of public officials, officers and representatives of the Company, and have made such other investigations as I have deemed necessary or appropriate under the circumstances.

 

In my examination, I have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to me as original documents and the conformity to original documents of all documents submitted to me as certified, conformed, facsimile, electronic or photostatic copies. I have relied upon the statements contained in the Registration Statement and certificates of officers of the Company, and I have made no independent investigation with regard thereto.

 

Based upon the foregoing and in reliance thereon, it is my opinion that the 20,000,000 shares of Common Stock being offered by the Company under the Registration Statement, when sold, will be legally issued, fully paid and non-assessable pursuant to the laws of the State of Nevada and the laws of the United States of America.

 

 C: 

  C: 61

 

 

I hereby consent to this opinion being included as an exhibit to the Registration Statement and to the use of my name under the caption “EXPERTS” in the prospectus constituting a part thereof.  

 

 

MCMURDO LAW GROUP, INC.

 
     
  /s/ Matthew McMurdo, Esq.  
  Matthew McMurdo, Esq.  

 

 C: 

 62


19 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/20/23  Adorbs Inc.                       10-Q        9/30/23   41:2.4M                                   Empire Filings/FA
 9/27/23  Soul Biotechnology Corp.          10-Q        6/30/23   41:2.4M                                   Empire Filings/FA
 8/07/23  Soul Biotechnology Corp.          S-1                   41:5.4M                                   Empire Filings/FA
 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA
10/21/22  Soul Biotechnology Corp.          10-Q        9/30/22   38:2.4M                                   Empire Filings/FA
 8/01/22  Soul Biotechnology Corp.          10-Q        6/30/22   38:2.1M                                   Empire Filings/FA
 5/10/22  Soul Biotechnology Corp.          10-Q        3/31/22   38:1.8M                                   Empire Filings/FA
 2/10/22  Soul Biotechnology Corp.          8-K:1,2,3,5 2/10/22   14:1.2M                                   Empire Filings/FA
 2/08/22  Soul Biotechnology Corp.          10-K       12/31/21   29:1.4M                                   Empire Filings/FA
12/09/21  Soul Biotechnology Corp.          10-K/A     12/31/20   28:1M                                     Empire Filings/FA
10/13/21  Soul Biotechnology Corp.          10-Q        9/30/21   29:1.3M                                   Empire Filings/FA
 7/23/21  Soul Biotechnology Corp.          10-Q        6/30/21   29:1.3M                                   Empire Filings/FA
 5/03/21  Soul Biotechnology Corp.          10-Q        3/31/21   28:926K                                   EdgarAgents LLC/FA
 2/10/21  Soul Biotechnology Corp.          10-K       12/31/20   28:1.1M                                   EdgarAgents LLC/FA
12/22/20  Soul Biotechnology Corp.          10-12G/A               4:704K                                   EdgarAgents LLC/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA
11/18/20  Soul Biotechnology Corp.          10-12G/A               6:838K                                   EdgarAgents LLC/FA
10/07/20  Soul Biotechnology Corp.          10-12G                 4:598K                                   EdgarAgents LLC/FA
 2/16/18  SEC                               UPLOAD4/11/18    1:138K Soul Biotechnology Corp.
Top
Filing Submission 0001615774-18-000439   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:06:43.1am ET